Pomalid Capsule is used in the treatment of multiple myeloma and is used in combination with some other medicine (dexamethasone). It works by helping the bone marrow to produce normal blood cells and by killing abnormal cells.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Pomalid (Pomalidomide) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 / 9891296838 or Email Us to know more details about the medicine and its cost price in India.
The order for Pomalid (Pomalidomide) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Pomalidomide is used to treat a type of cancer in the bone marrow (multiple myeloma). It works by slowing or stopping the growth of cancer cells. Pomalidomide affects the immune system. It promotes immune responses to help slow tumor growth.
MEKTOVI® (binimetinib) tablets, for oral use. Initial U.S. Approval: 2018
Generic Name: binimetinib
Tablets: 15 mg.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Pomalid (Pomalidomide) on prescription and Import License in Patient's Name only.
For overseas patients, Pomalid (Pomalidomide) can be made available in Send your enquiry to find Pomalid (Pomalidomide) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.